Dr. Brian M. Curtis, M.D.
Internal Medicine (Internal Medicine Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 350
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
OR license MD23056
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 350
- Services billed
- 2,362
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 399 | 246 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 137 | 137 |
| Administration of influenza virus vaccine | 51 | 51 |
| Influenza vaccine split virus, preservative free | 49 | 49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 38 | 36 |
| Established patient office or other outpatient visit, 20-29 minutes | 38 | 36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | 20 |
| Admn sarscov2 vacc 1 dose | 21 | 21 |
| Sarscv2 vac 30mcg trs-suc im | 21 | 21 |
| Dxa bone density measurement of hip, pelvis, spine | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Corvallis, OR | 592 |
| Levothyroxine Sodium Other prescribers in Corvallis, OR | 572 |
| Losartan Potassium Other prescribers in Corvallis, OR | 529 |
| Rosuvastatin Calcium Other prescribers in Corvallis, OR | 351 |
| Lisinopril Other prescribers in Corvallis, OR | 326 |
| Metoprolol Succinate Other prescribers in Corvallis, OR | 314 |
| Metformin Hcl Other prescribers in Corvallis, OR | 313 |
| Amlodipine Besylate Other prescribers in Corvallis, OR | 284 |
| Eliquis (apixaban) Other prescribers in Corvallis, OR | 273 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Corvallis, OR | 264 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $1,359 in research payments for these studies, mostly to the institutions running them.
- Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Eli Lilly and Company · Active, not recruiting · NCT06260722 - A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Eli Lilly and Company · Active, not recruiting · NCT05556512 - A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Eli Lilly and Company · Active, not recruiting · NCT05433584
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.